The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
Botulinum toxin A (BoNT-A) has been widely used in several urological functional disorders including neurogenic detrusor overactivity (NDO), overactive bladder (OAB), lower urinary tract dysfunction, and interstitial cystitis/bladder pain syndrome (IC/BPS). Chronic inflammation is found in a large p...
Main Authors: | Yuan-Hong Jiang, Jia-Fong Jhang, Hann-Chorng Kuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Tzu-Chi Medical Journal |
Subjects: | |
Online Access: | http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2023;volume=35;issue=1;spage=31;epage=37;aulast=Jiang |
Similar Items
-
Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
by: Jing-Liang Chen, et al.
Published: (2020-02-01) -
Treatment Outcomes of Intravesical Botulinum Toxin A Injections on Patients with Interstitial Cystitis/Bladder Pain Syndrome
by: Wan-Ru Yu, et al.
Published: (2022-12-01) -
Intravesical Botulinum Toxin Injection Plus Hydrodistention Is More Effective in Patients with Bladder Pain-Predominant Interstitial Cystitis/Bladder Pain Syndrome
by: Wan-Ru Yu, et al.
Published: (2024-02-01) -
Adverse Events of Intravesical Onabotulinum Toxin A Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
by: Yuh-Chen Kuo, et al.
Published: (2016-03-01) -
Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders
by: Fan-Ching Hung, et al.
Published: (2022-12-01)